Cargando…

DNA copy number analysis of metastatic urothelial carcinoma with comparison to primary tumors

BACKGROUND: To date, there have been no reports characterizing the genome-wide somatic DNA chromosomal copy-number alteration landscape in metastatic urothelial carcinoma. We sought to characterize the DNA copy-number profile in a cohort of metastatic samples and compare them to a cohort of primary...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bambury, Richard M, Bhatt, Ami S, Riester, Markus, Pedamallu, Chandra Sekhar, Duke, Fujiko, Bellmunt, Joaquim, Stack, Edward C, Werner, Lillian, Park, Rachel, Iyer, Gopa, Loda, Massimo, Kantoff, Philip W, Michor, Franziska, Meyerson, Matthew, Rosenberg, Jonathan E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4392457/ https://www.ncbi.nlm.nih.gov/pubmed/25886454 http://dx.doi.org/10.1186/s12885-015-1192-2

Ejemplares similares

FGFR3 expression in primary and metastatic urothelial carcinoma of the bladder
por: Guancial, Elizabeth A, et al.
Publicado: (2014)

HER2 as a target in invasive urothelial carcinoma
por: Bellmunt, Joaquim, et al.
Publicado: (2015)

Somatic Copy Number Abnormalities and Mutations in PI3K/AKT/mTOR Pathway Have Prognostic Significance for Overall Survival in Platinum Treated Locally Advanced or Metastatic Urothelial Tumors
por: Bellmunt, Joaquim, et al.
Publicado: (2015)

Metagenomic Characterization of Microbial Communities In Situ Within the Deeper Layers of the Ileum in Crohn’s Disease
por: Pedamallu, Chandra Sekhar, et al.
Publicado: (2016)

Emerging biomarkers in urothelial carcinoma: Challenges and opportunities
por: Andreatos, Nikolaos, et al.
Publicado: (2020)

Advanced Urothelial Carcinoma: Overcoming Treatment Resistance through Novel Treatment Approaches
por: Bambury, Richard M., et al.
Publicado: (2013)

Identification of ALK Gene Alterations in Urothelial Carcinoma
por: Bellmunt, Joaquim, et al.
Publicado: (2014)

Correlation of Apobec Mrna Expression with overall Survival and pd-l1 Expression in Urothelial Carcinoma
por: Mullane, Stephanie A., et al.
Publicado: (2016)

Urothelial carcinoma management in elderly or unfit patients()
por: Bellmunt, Joaquim, et al.
Publicado: (2016)

Kmt2a cooperates with menin to suppress tumorigenesis in mouse pancreatic islets
por: Lin, Wenchu, et al.
Publicado: (2016)

Open source tool for prediction of genome wide protein-protein interaction network based on ortholog information
por: Pedamallu, Chandra Sekhar, et al.
Publicado: (2010)

GATK PathSeq: a customizable computational tool for the discovery and identification of microbial sequences in libraries from eukaryotic hosts
por: Walker, Mark A, et al.
Publicado: (2018)

Pembrolizumab in the treatment of locally advanced or metastatic urothelial carcinoma: clinical trial evidence and experience
por: Crist, Michael, et al.
Publicado: (2019)

Upper tract urothelial carcinoma: a different disease entity in terms of management
por: Leow, Jeffrey J, et al.
Publicado: (2017)

Mocetinostat for patients with previously treated, locally advanced/metastatic urothelial carcinoma and inactivating alterations of acetyltransferase genes
por: Grivas, Petros, et al.
Publicado: (2018)

Transcriptomic analysis of micropapillary high grade T1 urothelial bladder cancer
por: Bowden, Michaela, et al.
Publicado: (2020)

Faster Protein Splicing with the Nostoc punctiforme DnaE Intein Using Non-native Extein Residues
por: Cheriyan, Manoj, et al.
Publicado: (2013)

A Pan-Cancer Analysis of Transcriptome Changes Associated with Somatic Mutations in U2AF1 Reveals Commonly Altered Splicing Events
por: Brooks, Angela N., et al.
Publicado: (2014)

Atezolizumab in patients with renal insufficiency and mixed variant histology: analyses from an expanded access program in platinum-treated locally advanced or metastatic urothelial carcinoma
por: Hoffman-Censits, Jean, et al.
Publicado: (2020)

The impact of prior platinum therapy on survival in patients with metastatic urothelial cancer receiving vinflunine
por: Harshman, L C, et al.
Publicado: (2013)

A Differentiation-Based Phylogeny of Cancer Subtypes
por: Riester, Markus, et al.
Publicado: (2010)

Cloning of NruI and Sbo13I restriction and modification sstems in E. coli and amino acid sequence comparison of M.NruI and M.Sbo13I with other amino-methyltransferases
por: Zhu, Zhenyu, et al.
Publicado: (2010)

Everolimus and pazopanib (E/P) benefit genomically selected patients with metastatic urothelial carcinoma
por: Bellmunt, Joaquim, et al.
Publicado: (2018)

A phase II trial of durvalumab and tremelimumab in metastatic, non‐urothelial carcinoma of the urinary tract
por: Sarfaty, Michal, et al.
Publicado: (2020)

Association of tumour microRNA profiling with outcomes in patients with advanced urothelial carcinoma receiving first-line platinum-based chemotherapy
por: Bellmunt, Joaquim, et al.
Publicado: (2016)

An Evolutionary Approach for Identifying Driver Mutations in Colorectal Cancer
por: Foo, Jasmine, et al.
Publicado: (2015)

Copy Number Signatures and Clinical Outcomes in Upper Tract Urothelial Carcinoma
por: Guan, Bao, et al.
Publicado: (2021)

Apatorsen plus docetaxel versus docetaxel alone in platinum-resistant metastatic urothelial carcinoma (Borealis-2)
por: Rosenberg, Jonathan E., et al.
Publicado: (2018)

A Case Report Demonstrating the Potential Clinical Benefit of Exhaustive Molecular Profiling in an Aggressive Muscle-Invasive High-Grade Metastatic Urothelial Carcinoma
por: Ramírez de Olano, Amaya, et al.
Publicado: (2017)

Complete hematologic response of early T-cell progenitor acute lymphoblastic leukemia to the γ-secretase inhibitor BMS-906024: genetic and epigenetic findings in an outlier case
por: Knoechel, Birgit, et al.
Publicado: (2015)

Identification of Nine Genomic Regions of Amplification in Urothelial Carcinoma, Correlation with Stage, and Potential Prognostic and Therapeutic Value
por: Chekaluk, Yvonne, et al.
Publicado: (2013)

Distance in cancer gene expression from stem cells predicts patient survival
por: Riester, Markus, et al.
Publicado: (2017)

Genomic heterogeneity as a barrier to precision oncology in urothelial cancer
por: Clinton, Timothy N., et al.
Publicado: (2022)

The impact of mutational clonality in predicting the response to immune checkpoint inhibitors in advanced urothelial cancer
por: Boll, Lilian Marie, et al.
Publicado: (2023)

Stem-Like Signature Predicting Disease Progression in Early Stage Bladder Cancer. The Role of E2F3 and SOX4
por: Bellmunt, Joaquim
Publicado: (2018)

Copy number alterations in urothelial carcinomas: their clinicopathological significance and correlation with DNA methylation alterations
por: Nishiyama, Naotaka, et al.
Publicado: (2011)

Venous thromboembolism in metastatic urothelial carcinoma or variant histologies: incidence, associative factors, and effect on survival
por: Ramos, Jorge D., et al.
Publicado: (2016)

Functional Copy-Number Alterations in Cancer
por: Taylor, Barry S., et al.
Publicado: (2008)

Punctuated Copy Number Evolution and Clonal Stasis in Triple-Negative Breast Cancer
por: Gao, Ruli, et al.
Publicado: (2016)

DNA copy number alterations and PPARG amplification in a patient with multifocal bladder urothelial carcinoma
por: Conconi, Donatella, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_vrvj16429a4jh74ddso3nscn55